Literature DB >> 18270675

[Sympathomimetic effects of low-dose S(+)-ketamine. Effect of propofol dosage].

Claudia Timm1, U Linstedt, T Weiss, M Zenz, C Maier.   

Abstract

BACKGROUND: In analgetic dosages ketamine has stimulatory effects on the cardiovascular system, which limits its use in patients with heart disease. The aim of this study was to clarify whether low-dose S(+)-ketamine used to prevent chronic pain similarly stimulates the cardiovascular system and to determine the impact of propofol dosage on this effect.
METHODS: A total of 80 patients undergoing surgery under spinal or epidural anesthesia were randomly assigned to receive double-blinded S(+)-ketamine [0.25 mg/kg body weight (BW) bolus followed by infusion of 0.06 mg/kg BW/h] or placebo in the presence of continuous propofol infusion (2-5 mg/kg BW/h). The heart rate, blood pressure and calculated rate-pressure product (RPP) were monitored.
RESULTS: Following the S(+)-ketamine bolus, the heart rate, blood pressure and RPP increased significantly. In the presence of a propofol dosage >3 mg/kg BW/h the stimulatory cardiovascular effect could no longer be observed.
CONCLUSION: Even low-dose S(+)-ketamine has a stimulatory effect on the cardiovascular system. This stimulatory effect is nullified in the presence of a continuous propofol infusion at a dosage of more than 3 mg/kg BW/h.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18270675     DOI: 10.1007/s00101-008-1331-0

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  29 in total

1.  Cognitive impairment after small-dose ketamine isomers in comparison to equianalgesic racemic ketamine in human volunteers.

Authors:  Ernst G Pfenninger; Marcel E Durieux; Sabine Himmelseher
Journal:  Anesthesiology       Date:  2002-02       Impact factor: 7.892

2.  The effect of ketamine on catecholamine metabolism in the isolated perfused rat heart.

Authors:  D J Miletich; A D Ivankovic; R F Albrecht; B Zahed; A A Ilahi
Journal:  Anesthesiology       Date:  1973-09       Impact factor: 7.892

3.  Ketamine and plasma catecholamines.

Authors:  S Takki; P Nikki; A Jäättelä; T Tammisto
Journal:  Br J Anaesth       Date:  1972-12       Impact factor: 9.166

Review 4.  Heart rate and the rate-pressure product as determinants of cardiovascular risk in patients with hypertension.

Authors:  W B White
Journal:  Am J Hypertens       Date:  1999-02       Impact factor: 2.689

5.  A critical appraisal of the rate pressure product as index of myocardial oxygen consumption for the study of metabolic coronary flow regulation.

Authors:  J E Kal; H B Van Wezel; I Vergroesen
Journal:  Int J Cardiol       Date:  1999-10-31       Impact factor: 4.164

6.  Relation of heart rate and systolic blood pressure to the onset of pain in angina pectoris.

Authors:  B F Robinson
Journal:  Circulation       Date:  1967-06       Impact factor: 29.690

7.  Intraoperative blood pressure. What patterns identify patients at risk for postoperative complications?

Authors:  M E Charlson; C R MacKenzie; J P Gold; K L Ales; M Topkins; G T Shires
Journal:  Ann Surg       Date:  1990-11       Impact factor: 12.969

8.  Oral ketamine therapy in the treatment of postamputation stump pain.

Authors:  L Nikolajsen; P O Hansen; T S Jensen
Journal:  Acta Anaesthesiol Scand       Date:  1997-03       Impact factor: 2.105

9.  Differential effects of ketamine isomers on neuronal and extraneuronal catecholamine uptake mechanisms.

Authors:  P M Lundy; P A Lockwood; G Thompson; R Frew
Journal:  Anesthesiology       Date:  1986-03       Impact factor: 7.892

10.  [The action of S-(+)-ketamine on serum catecholamine and cortisol. A comparison with ketamine racemate].

Authors:  A Doenicke; R Angster; M Mayer; H A Adams; G Grillenberger; A E Nebauer
Journal:  Anaesthesist       Date:  1992-10       Impact factor: 1.041

View more
  8 in total

Review 1.  Ketamine for chronic pain: risks and benefits.

Authors:  Marieke Niesters; Christian Martini; Albert Dahan
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

2.  Premedication with fentanyl-midazolam improves sevoflurane anesthesia for surgical intervention in laboratory mice.

Authors:  Miriam Lipiski; Margarete Arras; Paulin Jirkof; Nikola Cesarovic
Journal:  Exp Biol Med (Maywood)       Date:  2017-05-05

3.  Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study.

Authors:  Laura Kranaster; Jutta Kammerer-Ciernioch; Carolin Hoyer; Alexander Sartorius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-03-13       Impact factor: 5.270

4.  Ketofol-Dexmedetomidine combination in ECT: A punch for depression and agitation.

Authors:  Tarek Shams; Ragaa El-Masry
Journal:  Indian J Anaesth       Date:  2014-05

5.  Ketamine in outpatient arthroscopic shoulder surgery: Effects on postoperative pain, hemodynamic stability and process times.

Authors:  Hanna Schotola; Karl-Christian Kirsch; Jan Höcker; Michael Egan; Benedikt Büttner; Christoph Wiese; Ashham Mansur; José Maria Hinz; Ingo Bergmann
Journal:  Open Med (Wars)       Date:  2015-05-28

6.  Comparison of efficacy of ketamine versus thiopentone-assisted modified electroconvulsive therapy in major depression.

Authors:  Amit Jagtiani; Hitesh Khurana; Naveen Malhotra
Journal:  Indian J Psychiatry       Date:  2019 May-Jun       Impact factor: 1.759

7.  Optimum dose of spinal ropivacaine with or without single intravenous bolus of S-ketamine during elective cesarean delivery: a randomized, double-blind, sequential dose-finding study.

Authors:  Xiaoyu Zhang; Jianwei Wang; Xiao-Hu An; Yu-Chieh Chao; Yong Bian; Zifeng Xu; Tao Xu
Journal:  BMC Pregnancy Childbirth       Date:  2021-11-04       Impact factor: 3.007

8.  Antidepressant Effect of Combined Ketamine and Electroconvulsive Therapy on Patients With Major Depressive Disorder: A Randomized Trial.

Authors:  Narges Shams Alizadeh; Azad Maroufi; Karim Nasseri; Seyed Hosein Sadeghi Najafabadi; Ali Mousavi Taghiabad; Fardin Gharibi; Gholam Reza Esfandiari
Journal:  Iran J Psychiatry Behav Sci       Date:  2015-09-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.